SCHEMBL968784

SCHEMBL968784

CCC(=O)Oc1cccc(C(=O)Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.58
ELANE P08246 1/20 0.53
KMT2A Q03164 6/20 0.49
ESR1 P03372 3/20 0.49
HIF1A Q16665 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RECQL P46063 1/20 0.49
MAPT P10636 2/20 0.45
MEN1 O00255 2/20 0.45
HTT P42858 1/20 0.45
LMNA P02545 2/20 0.44
KDM4E B2RXH2 2/20 0.44
USP2 O75604 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
MAPK1 P28482 2/20 0.44
HSD17B10 Q99714 2/20 0.44
NPC1 O15118 1/20 0.44
ALOX15 P16050 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4250289 0.85 KMT2A (0.61) ACHEELANEKMT2AESR1HIF1A
SCHEMBL27490878 0.85 ACHE (0.59) ACHEELANEKMT2AESR1HIF1A
SCHEMBL29492633 0.85 KMT2A (0.61) ACHEELANEKMT2AESR1HIF1A
SCHEMBL10782553 0.84 ACHE (0.71) ACHEELANEKMT2AESR1HIF1A
SCHEMBL24359987 0.83 PARP1 (0.62) ACHEELANEKMT2AESR1HIF1A
SCHEMBL11444965 0.82 ACHE (0.69) ACHEELANEKMT2AESR1HIF1A
SCHEMBL10447424 0.82 ELANE (0.73) ACHEELANEKMT2AESR1HIF1A
SCHEMBL539733 0.81 LMNA (0.59) ACHEELANEKMT2AESR1SMN1; SMN2
Hydrochloric Acid SCHEMBL25263792 0.81 ELANE (0.71) ACHEELANEKMT2AESR1HIF1A
SCHEMBL22619020 0.79 ACHE (0.61) ACHEELANEKMT2AESR1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009584-A1 Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety GEORGIA TECH RESEARCH CORPORATION (US) 2011-01-13 US disclosed
EP-2234991-A1 ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY Georgia Tech Research Corporation (US) 2010-10-06 EP disclosed
WO-2009080797-A1 ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY GEORGIA TECH RESEARCH CORPORATION (US) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009584-A1 Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety SLCO1B3, SLCO4C1, SLCO2B1 ACHE 4603/4885ELANE 2612/4885KMT2A 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.